|
|
CRNX
|
Stock |
Healthcare
|
US$ 9.01 B
|
0,85% |
|
Indivior PLC Ordinary Shares
|
INDV
|
Stock |
Healthcare
|
US$ 4.28 B
|
0,79% |
|
|
ATAI
|
Stock |
Healthcare
|
US$ 2.72 B
|
0,67% |
|
|
XERS
|
Stock |
Healthcare
|
US$ 1.89 B
|
0,58% |
|
Veradermics, Incorporated
|
MANE
|
Stock |
Healthcare
|
US$ 5.58 B
|
0,58% |
|
|
PCRX
|
Stock |
Healthcare
|
US$ 1.45 B
|
0,58% |
|
|
LLY
|
Stock |
Healthcare
|
US$ 1.26 T
|
0,55% |
Amneal Pharmaceuticals, Inc. Class A Common Stock
|
AMRX
|
Stock |
Healthcare
|
US$ 6.95 B
|
0,54% |
|
|
SUPN
|
Stock |
Healthcare
|
US$ 2.47 B
|
0,52% |
|
|
VTRS
|
Stock |
Healthcare
|
US$ 21.73 B
|
0,52% |
Maze Therapeutics, Inc. Common Stock
|
MAZE
|
Stock |
Healthcare
|
US$ 1.79 B
|
0,52% |
|
|
LGND
|
Stock |
Healthcare
|
US$ 6.27 B
|
0,49% |
|
|
PFE
|
Stock |
Healthcare
|
US$ 170.99 B
|
0,48% |
|
|
ZTS
|
Stock |
Healthcare
|
US$ 34.29 B
|
0,47% |
|
|
RPRX
|
Stock |
Healthcare
|
US$ 38.37 B
|
0,47% |
|
|
ELAN
|
Stock |
Healthcare
|
US$ 12.65 B
|
0,47% |
Septerna, Inc. Common Stock
|
SEPN
|
Stock |
Healthcare
|
US$ 2.23 B
|
0,47% |
|
|
PRGO
|
Stock |
Healthcare
|
US$ 2.17 B
|
0,46% |
Prestige Brand Holdings Inc
|
PBH
|
Stock |
Healthcare
|
US$ 2.52 B
|
0,45% |
|
|
MRK
|
Stock |
Healthcare
|
US$ 356.93 B
|
0,44% |
|
|
ANIP
|
Stock |
Healthcare
|
US$ 1.65 B
|
0,44% |
|
|
NKTR
|
Stock |
Healthcare
|
US$ 2.53 B
|
0,43% |
|
|
OGN
|
Stock |
Healthcare
|
US$ 3.64 B
|
0,43% |
|
|
COLL
|
Stock |
Healthcare
|
US$ 772.54 M
|
0,43% |
|
|
JAZZ
|
Stock |
Healthcare
|
US$ 14.91 B
|
0,42% |
|
|
BMY
|
Stock |
Healthcare
|
US$ 131.21 B
|
0,42% |
|
|
JNJ
|
Stock |
Healthcare
|
US$ 640.75 B
|
0,42% |
|
|
INVA
|
Stock |
Healthcare
|
US$ 1.51 B
|
0,41% |
|
|
AMLX
|
Stock |
Healthcare
|
US$ 3.66 B
|
0,40% |
|
|
OMER
|
Stock |
Healthcare
|
US$ 1.32 B
|
0,39% |
|
|
HRMY
|
Stock |
Healthcare
|
US$ 2.16 B
|
0,39% |
|
|
ETON
|
Stock |
Healthcare
|
US$ 1.45 B
|
0,39% |
|
|
EWTX
|
Stock |
Healthcare
|
US$ 4.09 B
|
0,38% |
|
|
TARS
|
Stock |
Healthcare
|
US$ 3.40 B
|
0,38% |
|
MBX Biosciences, Inc. Common Stock
|
MBX
|
Stock |
Healthcare
|
US$ 2.65 B
|
0,37% |
|
|
AMPH
|
Stock |
Healthcare
|
US$ 1.15 B
|
0,37% |
|
|
TRVI
|
Stock |
Healthcare
|
US$ 1.97 B
|
0,37% |
|
|
DFTX
|
Stock |
Healthcare
|
US$ 4.49 B
|
0,37% |
Enliven Therapeutics Inc.
|
ELVN
|
Stock |
Healthcare
|
US$ 3.46 B
|
0,34% |
|
|
KMPH
|
Stock |
Healthcare
|
US$ 200.47 M
|
0,33% |
|
|
NUVB
|
Stock |
Healthcare
|
US$ 1.65 B
|
0,33% |
|
|
HROW
|
Stock |
Healthcare
|
US$ 1.07 B
|
0,33% |
|
LB Pharmaceuticals Inc Common Stock
|
LBRX
|
Stock |
Healthcare
|
US$ 1.30 B
|
0,32% |
|
|
CORT
|
Stock |
Healthcare
|
US$ 8.56 B
|
0,31% |
Alumis Inc
|
ALMS
|
Stock |
Healthcare
|
US$ 847.80 M
|
0,30% |
|
|
WVE
|
Stock |
Healthcare
|
US$ 706.08 M
|
0,29% |
|
|
AXSM
|
Stock |
Healthcare
|
US$ 7.34 B
|
0,28% |
|
|
LQDA
|
Stock |
Healthcare
|
US$ 4.24 B
|
0,27% |
|
|
PAHC
|
Stock |
Healthcare
|
US$ 1.60 B
|
0,26% |
|
|
OCUL
|
Stock |
Healthcare
|
US$ 1.50 B
|
0,26% |
|
|
RLMD
|
Stock |
Healthcare
|
US$ 455.48 M
|
0,24% |
Alto Neuroscience, Inc.
|
ANRO
|
Stock |
Healthcare
|
US$ 890.80 M
|
0,24% |
Rapport Therapeutics, Inc. Common Stock
|
RAPP
|
Stock |
Healthcare
|
US$ 1.47 B
|
0,24% |
|
|
AQST
|
Stock |
Healthcare
|
US$ 476.94 M
|
0,21% |
|
|
CRMD
|
Stock |
Healthcare
|
US$ 433.37 M
|
0,20% |
|
|
PHAT
|
Stock |
Healthcare
|
US$ 466.61 M
|
0,20% |
|
|
ACRS
|
Stock |
Healthcare
|
US$ 579.64 M
|
0,19% |
|
Avalyn Pharma Inc. Common Stock
|
AVLN
|
Stock |
Healthcare
|
US$ 1.19 B
|
0,17% |
|
|
ARVN
|
Stock |
Healthcare
|
US$ 486.01 M
|
0,16% |
|
|
LXRX
|
Stock |
Healthcare
|
US$ 649.64 M
|
0,15% |
|
|
EOLS
|
Stock |
Healthcare
|
US$ 493.40 M
|
0,15% |
BioAge Labs, Inc
|
BIOA
|
Stock |
Healthcare
|
US$ 273.09 M
|
0,13% |
Contineum Therapeutics, Inc. Class A Common Stock
|
CTNM
|
Stock |
Healthcare
|
US$ 364.55 M
|
0,10% |
|
|
EYPT
|
Stock |
Healthcare
|
US$ 33.12 M
|
0,02% |
|
|
ESPR
|
Stock |
Healthcare
|
US$ 819.46 M
|
0,00% |